{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:40:57Z","timestamp":1790714457736,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192123"],"award-info":[{"award-number":["7192123"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770793"],"award-info":[{"award-number":["31770793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31530026"],"award-info":[{"award-number":["31530026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral malaria (CM) is a life-threatening diffuse encephalopathy caused by <jats:italic>Plasmodium falciparum<\/jats:italic>, in which the destruction of the blood\u2013brain barrier (BBB) is the main cause of death. However, increasing evidence has shown that antimalarial drugs, the current treatment for CM, do little to protect against CM-induced BBB damage. Therefore, a means to alleviate BBB dysfunction would be a promising adjuvant therapy for CM. The adhesion molecule CD146 has been reported to be expressed in both endothelial cells and proinflammatory immune cells and mediates neuroinflammation. Here, we demonstrate that CD146 expressed on BBB endothelial cells but not immune cells is a novel therapeutic target in a mouse model of experimental cerebral malaria (eCM). Endothelial CD146 is upregulated during eCM development and facilitates the sequestration of infected red blood cells (RBCs) and\/or proinflammatory lymphocytes in CNS blood vessels, thereby promoting the disruption of BBB integrity. Mechanistic studies showed that the interaction of CD146 and Galectin-9 contributes to the aggregation of infected RBCs and lymphocytes. Deletion of endothelial CD146 or treatment with the anti-CD146 antibody AA98 prevents severe signs of eCM, such as limb paralysis, brain vascular leakage, and death. In addition, AA98 combined with the antiparasitic drug artemether improved the cognition and memory of mice with eCM. Taken together, our findings suggest that endothelial CD146 is a novel and promising target in combination with antiparasitic drugs for future CM therapies.<\/jats:p>","DOI":"10.1038\/s41423-020-00582-8","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T08:02:57Z","timestamp":1605600177000},"page":"2443-2454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeting the CD146\/Galectin-9 axis protects the integrity of the blood\u2013brain barrier in experimental cerebral malaria"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-1228","authenticated-orcid":false,"given":"Hongxia","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1488-2601","authenticated-orcid":false,"given":"Shuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gramaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"582_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.lindif.2015.01.010","volume":"46","author":"P Bangirana","year":"2016","unstructured":"Bangirana, P. et al. Neurocognitive domains affected by cerebral malaria and severe malarial anemia in children. Learn. Individ. Differ. 46, 38\u201344 (2016).","journal-title":"Learn. Individ. Differ."},{"key":"582_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S2221-1691(13)60108-2","volume":"3","author":"B Peixoto","year":"2013","unstructured":"Peixoto, B. & Kalei, I. Neurocognitive sequelae of cerebral malaria in adults: a pilot study in Benguela Central Hospital, Angola. Asian Pac. J. Trop. Biomed. 3, 532\u2013535 (2013).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"582_CR3","first-page":"CD000972","volume":"2","author":"K Prasad","year":"2000","unstructured":"Prasad, K. & Garner, P. Steroids for treating cerebral malaria. Cochrane Database Syst. Rev.\u00a02, CD000972 (2000).","journal-title":"Cochrane Database Syst. Rev."},{"key":"582_CR4","first-page":"91","volume":"86","author":"D Kwiatkowski","year":"1993","unstructured":"Kwiatkowski, D. et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J. Med 86, 91\u201398 (1993).","journal-title":"Q J. Med"},{"key":"582_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1056\/NEJM199211193272101","volume":"327","author":"V Gordeuk","year":"1992","unstructured":"Gordeuk, V. et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med 327, 1473\u20131477 (1992).","journal-title":"N. Engl. J. Med"},{"key":"582_CR6","first-page":"CD001474","volume":"2","author":"HJ Smith","year":"2003","unstructured":"Smith, H. J. & Meremikwu, M. Iron chelating agents for treating malaria. Cochrane Database Syst. Rev.\u00a02, CD001474 (2003).","journal-title":"Cochrane Database Syst. Rev"},{"key":"582_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0140-6736(99)07148-2","volume":"355","author":"J Crawley","year":"2000","unstructured":"Crawley, J. et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet 355, 701\u2013706 (2000).","journal-title":"Lancet"},{"key":"582_CR8","first-page":"CD002152","volume":"2","author":"M Meremikwu","year":"2002","unstructured":"Meremikwu, M. & Marson, A. G. Routine anticonvulsants for treating cerebral malaria. Cochrane Database Syst. Rev.\u00a02, CD002152 (2002).","journal-title":"Cochrane Database Syst. Rev"},{"key":"582_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/cir405","volume":"53","author":"S Mohanty","year":"2011","unstructured":"Mohanty, S. et al. Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin. Infect. Dis. 53, 349\u2013355 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"582_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/CCM.0b013e3181958dfd","volume":"37","author":"P Charunwatthana","year":"2009","unstructured":"Charunwatthana, P. et al. N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit. Care Med. 37, 516\u2013522 (2009).","journal-title":"Crit. Care Med."},{"key":"582_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1586\/eri.10.90","volume":"8","author":"CC John","year":"2010","unstructured":"John, C. C., Kutamba, E., Mugarura, K. & Opoka, R. O. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev. Anti Infect. Ther. 8, 997\u20131008 (2010).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"582_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.pt.2019.04.010","volume":"35","author":"G Nishanth","year":"2019","unstructured":"Nishanth, G. & Schluter, D. Blood-brain barrier in cerebral malaria: pathogenesis and therapeutic intervention. Trends Parasitol. 35, 516\u2013528 (2019).","journal-title":"Trends Parasitol."},{"key":"582_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fcimb.2017.00324","volume":"7","author":"J Dunst","year":"2017","unstructured":"Dunst, J., Kamena, F. & Matuschewski, K. Cytokines and chemokines in cerebral malaria pathogenesis. Front Cell Infect. Microbiol. 7, 324 (2017).","journal-title":"Front Cell Infect. Microbiol"},{"key":"582_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fcimb.2014.00100","volume":"4","author":"J Storm","year":"2014","unstructured":"Storm, J. & Craig, A. G. Pathogenesis of cerebral malaria-inflammation and cytoadherence. Front Cell Infect. Microbiol. 4, 100 (2014).","journal-title":"Front Cell Infect. Microbiol"},{"key":"582_CR15","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1182\/blood-2012-01-406108","volume":"120","author":"T Jiang","year":"2012","unstructured":"Jiang, T. et al. CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood 120, 2330\u20132339 (2012).","journal-title":"Blood"},{"key":"582_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1182\/blood-2002-04-1004","volume":"102","author":"X Yan","year":"2003","unstructured":"Yan, X. et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102, 184\u2013191 (2003).","journal-title":"Blood"},{"key":"582_CR17","doi-asserted-by":"publisher","first-page":"E7622","DOI":"10.1073\/pnas.1710848114","volume":"114","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. CD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development. Proc. Natl Acad. Sci. USA 114, E7622\u2013E7631 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"582_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep01687","volume":"3","author":"H Duan","year":"2013","unstructured":"Duan, H. et al. Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS. Sci. Rep. 3, 1687 (2013).","journal-title":"Sci. Rep."},{"key":"582_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.autrev.2015.01.003","volume":"14","author":"PK Dagur","year":"2015","unstructured":"Dagur, P. K. & McCoy, J. P. Jr Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases. Autoimmun. Rev. 14, 415\u2013422 (2015).","journal-title":"Autoimmun. Rev."},{"key":"582_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/cr.2017.8","volume":"27","author":"Y Luo","year":"2017","unstructured":"Luo, Y. et al. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. Cell Res. 27, 352\u2013372 (2017).","journal-title":"Cell Res."},{"key":"582_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/hyb.2008.0034","volume":"27","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146. Hybrid. (Larchmt.) 27, 345\u2013352 (2008).","journal-title":"Hybrid. (Larchmt.)"},{"key":"582_CR22","first-page":"4219","volume":"27","author":"Y Lin","year":"2007","unstructured":"Lin, Y. et al. A novel antibody AA98 V(H)\/L directed against CD146 efficiently inhibits angiogenesis. Anticancer Res 27, 4219\u20134224 (2007).","journal-title":"Anticancer Res"},{"key":"582_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/nm1499","volume":"12","author":"I Gramaglia","year":"2006","unstructured":"Gramaglia, I. et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med 12, 1417\u20131422 (2006).","journal-title":"Nat. Med"},{"key":"582_CR24","doi-asserted-by":"publisher","first-page":"e13124","DOI":"10.1371\/journal.pone.0013124","volume":"5","author":"RW Carroll","year":"2010","unstructured":"Carroll, R. W. et al. A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PLoS ONE 5, e13124 (2010).","journal-title":"PLoS ONE"},{"key":"582_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1006\/nlme.1997.3746","volume":"67","author":"F Dellu","year":"1997","unstructured":"Dellu, F., Fauchey, V., Le Moal, M. & Simon, H. Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol. Learn Mem. 67, 112\u2013120 (1997).","journal-title":"Neurobiol. Learn Mem."},{"key":"582_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47\u201360 (1984).","journal-title":"J. Neurosci. Methods"},{"key":"582_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.ajpath.2014.01.031","volume":"184","author":"S Xing","year":"2014","unstructured":"Xing, S. et al. Targeting endothelial CD146 attenuates colitis and prevents colitis-associated carcinogenesis. Am. J. Pathol. 184, 1604\u20131616 (2014).","journal-title":"Am. J. Pathol."},{"key":"582_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pt.2009.10.007","volume":"26","author":"NJ White","year":"2010","unstructured":"White, N. J., Turner, G. D., Medana, I. M., Dondorp, A. M. & Day, N. P. The murine cerebral malaria phenomenon. Trends Parasitol. 26, 11\u201315 (2010).","journal-title":"Trends Parasitol."},{"key":"582_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1471-7","volume":"15","author":"BP Dembele","year":"2016","unstructured":"Dembele, B. P. et al. Plasma levels of Galectin-9 reflect disease severity in malaria infection. Malar. J. 15, 403 (2016).","journal-title":"Malar. J."},{"key":"582_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1182\/blood-2013-03-490219","volume":"122","author":"CA Moxon","year":"2013","unstructured":"Moxon, C. A. et al. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 122, 842\u2013851 (2013).","journal-title":"Blood"},{"key":"582_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/AAC.01479-15","volume":"60","author":"JM Brussee","year":"2016","unstructured":"Brussee, J. M., Yeo, T. W., Lampah, D. A., Anstey, N. M. & Duffull, S. B. Pharmacokinetic-pharmacodynamic model for the effect of l-arginine on endothelial function in patients with moderately severe falciparum malaria. Antimicrob. Agents Chemother. 60, 198\u2013205 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"582_CR32","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1017\/S1462399409001082","volume":"11","author":"JA Rowe","year":"2009","unstructured":"Rowe, J. A., Claessens, A., Corrigan, R. A. & Arman, M. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev. Mol. Med. 11, e16 (2009).","journal-title":"Expert Rev. Mol. Med"},{"key":"582_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.chom.2017.02.009","volume":"21","author":"F Lennartz","year":"2017","unstructured":"Lennartz, F. et al. Structure-guided identification of a family of dual receptor-binding PfEMP1 that is associated with cerebral malaria. Cell Host Microbe 21, 403\u2013414 (2017).","journal-title":"Cell Host Microbe"},{"key":"582_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4161\/viru.19013","volume":"3","author":"L Renia","year":"2012","unstructured":"Renia, L. et al. Cerebral malaria: mysteries at the blood-brain barrier. Virulence 3, 193\u2013201 (2012).","journal-title":"Virulence"},{"key":"582_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4049\/jimmunol.1202578","volume":"190","author":"A Bengtsson","year":"2013","unstructured":"Bengtsson, A. et al. A novel domain cassette identifies Plasmodium falciparum PfEMP1 proteins binding ICAM-1 and is a target of cross-reactive, adhesion-inhibitory antibodies. J. Immunol. 190, 240\u2013249 (2013).","journal-title":"J. Immunol."},{"key":"582_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.chom.2014.11.007","volume":"17","author":"CK Lau","year":"2015","unstructured":"Lau, C. K. et al. Structural conservation despite huge sequence diversity allows EPCR binding by the PfEMP1 family implicated in severe childhood malaria. Cell Host Microbe 17, 118\u2013129 (2015).","journal-title":"Cell Host Microbe"},{"key":"582_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12837","volume":"7","author":"FL Hsieh","year":"2016","unstructured":"Hsieh, F. L. et al. The structural basis for CD36 binding by the malaria parasite. Nat. Commun. 7, 12837 (2016).","journal-title":"Nat. Commun."},{"key":"582_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/glycob\/12.2.111","volume":"12","author":"S Chabot","year":"2002","unstructured":"Chabot, S. et al. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12, 111\u2013118 (2002).","journal-title":"Glycobiology"},{"key":"582_CR39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/ijms19020430","volume":"19","author":"FC Chou","year":"2018","unstructured":"Chou, F. C., Chen, H. Y., Kuo, C. C. & Sytwu, H. K. Role of galectins in tumors and in clinical immunotherapy. Int. J. Mol. Sci.\u00a019, 430 (2018).","journal-title":"Int. J. Mol. Sci"},{"key":"582_CR40","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6, 1245\u20131252 (2005).","journal-title":"Nat. Immunol."},{"key":"582_CR41","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1074\/jbc.M112.418848","volume":"288","author":"N Jouve","year":"2013","unstructured":"Jouve, N. et al. The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. J. Biol. Chem. 288, 2571\u20132579 (2013).","journal-title":"J. Biol. Chem."},{"key":"582_CR42","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1074\/jbc.M117.783431","volume":"292","author":"F Colomb","year":"2017","unstructured":"Colomb, F. et al. Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells. J. Biol. Chem. 292, 8381\u20138389 (2017).","journal-title":"J. Biol. Chem."},{"key":"582_CR43","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/1873-3468.13083","volume":"592","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., Zheng, Y., Wang, H., Zhou, Y. & Tai, G. CD146 interacts with galectin-3 to mediate endothelial cell migration. FEBS Lett. 592, 1817\u20131828 (2018).","journal-title":"FEBS Lett."},{"key":"582_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/glycob\/cwz036","volume":"29","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. NMR-based insight into galectin-3 binding to endothelial cell adhesion molecule CD146: Evidence for noncanonical interactions with the lectin\u2019s CRD beta-sandwich F-face. Glycobiology 29, 608\u2013618 (2019).","journal-title":"Glycobiology"},{"key":"582_CR45","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.biocel.2009.03.014","volume":"41","author":"C Zheng","year":"2009","unstructured":"Zheng, C. et al. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int J. Biochem. Cell Biol. 41, 2163\u20132172 (2009).","journal-title":"Int J. Biochem. Cell Biol."},{"key":"582_CR46","first-page":"592","volume":"8","author":"K Malpass","year":"2012","unstructured":"Malpass, K. Disease mechanisms in MS: Cell adhesion molecule MCAM on pathogenic T cells-a green light for CNS entry in multiple sclerosis. Nat. Rev. Neurol. 8, 592 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"582_CR47","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/1529-0131(199904)42:4<622::AID-ANR4>3.0.CO;2-Y","volume":"42","author":"M Neidhart","year":"1999","unstructured":"Neidhart, M. et al. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum. 42, 622\u2013630 (1999).","journal-title":"Arthritis Rheum."},{"key":"582_CR48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/cei.12434","volume":"179","author":"C Wu","year":"2015","unstructured":"Wu, C., Goodall, J. C., Busch, R. & Gaston, J. S. Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-gamma by CD4(+) T cells in patients with inflammatory arthritis. Clin. Exp. Immunol. 179, 378\u2013391 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"582_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.MIB.0000194181.46930.88","volume":"12","author":"N Bardin","year":"2006","unstructured":"Bardin, N. et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm. Bowel Dis. 12, 16\u201321 (2006).","journal-title":"Inflamm. Bowel Dis."},{"key":"582_CR50","first-page":"748","volume":"45","author":"L Li","year":"2006","unstructured":"Li, L., Zhang, B. R., Zeng, X. F. & Wang, X. [A pilot study on the significance of leucocyte CD146 expression in vasculitis]. Zhonghua Nei Ke Za Zhi 45, 748\u2013751 (2006).","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"582_CR51","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1084\/jem.20140540","volume":"211","author":"T Schneider-Hohendorf","year":"2014","unstructured":"Schneider-Hohendorf, T. et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J. Exp. Med. 211, 1833\u20131846 (2014).","journal-title":"J. Exp. Med"},{"key":"582_CR52","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.4197","volume":"230","author":"A Kratzer","year":"2013","unstructured":"Kratzer, A. et al. Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD. J. Pathol. 230, 388\u2013398 (2013).","journal-title":"J. Pathol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00582-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T09:19:44Z","timestamp":1632993584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-00582-8","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}